Point72 Asset
View Older Stories View More Recent Stories
-
reAlpha Tech appoints Thomas Kutzman as chief financial officer
-
reAlpha Tech Corp. Appoints Thomas Kutzman as Chief Financial Officer to Support Growth Strategy
-
Some private credit firms are using accounting tools to mask leverage, Rubric Capital tells investors
-
Form SCHEDULE 13G Beta Bionics, Inc. Filed by: Point72 Asset Management, L.P.
-
SummitTX Capital Elevates Neilson Arbour to Co-Chief Investment Officer
-
How Republicans are winning the war over US congressional redistricting, state by state
-
Form SCHEDULE 13G Q32 Bio Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G OKYO Pharma Ltd Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Century Therapeutics, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Kodiak Sciences Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A ADC Therapeutics SA Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A WOLFSPEED, INC. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Confluent, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Verastem, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A FG Nexus Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Cidara Therapeutics, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Praxis Precision Medicin Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A PagSeguro Digital Ltd. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Alto Neuroscience, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Korro Bio, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A IDEAYA Biosciences, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Design Therapeutics, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A PLIANT THERAPEUTICS, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A WOLVERINE WORLD WIDE Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Invivyd, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Aptevo Therapeutics Inc. Filed by: Point72 Asset Management, L.P.
-
Form 13F-HR Point72 Asset Management For: Dec 31
-
54% of Manhattan Real Estate Deals Are All Cash as Wealthy Buyers Sidestep Traditional Mortgages
-
Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund
-
Form SCHEDULE 13G IO Biotech, Inc. Filed by: Point72 Asset Management, L.P.
-
Cohen Veterans Network Marks a Decade of Innovation, Filling Mental Health Care Gaps for Post-9/11 Veterans, Service Members and Their Families
-
NeOnc Technologies secures $16 million PIPE investment led by Cinctive
-
NeOnc Technologies Secures Strategic PIPE Investment led by $10 Million Investment from Cinctive Capital Management
-
Cohen Veterans Network Partners with the Gary Sinise Foundation to Extend Its Proven Model of Mental Health Care to Serve Los Angeles Fire Department (LAFD) Uniformed Personnel and Their Families
-
Form SCHEDULE 13G PRECIGEN, INC. Filed by: Point72 Asset Management, L.P.
-
New Research from Cohen Veterans Network Aims to Identify Optimal Messaging for Lethal Means Safety Among Veterans
-
Apolo V Acquisition Corp. Enters into Definitive Agreement with Telyrx, Inc.
-
Form SCHEDULE 13G Infinite Eagle Acquisiti Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G Forte Biosciences, Inc. Filed by: Point72 Asset Management, L.P.
-
Cohen Veterans Network Announces Its First Mental Health Clinic in Kansas in Collaboration with the Robert R. McCormick Foundation to Treat Service Members, Veterans and Their Families Across the Stat
-
Strong year for hedge funds drives big gains for Wall Street's prime brokerage engine
-
Darkroom Names Former Rokt VP Peter Gao as SVP of Growth as the Agency Targets Industry-Shaping Brands
-
Form SCHEDULE 13G/A KalVista Pharmaceuticals Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G KalVista Pharmaceuticals Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G VNET Group, Inc. Filed by: Point72 Asset Management, L.P.
-
Water Tower Research (WTR) Adds Eric Goldstein as Managing Director – Mobility

